AzTrials
AzTrials

ACL TearNCT05532189

Anterior Cruciate Ligament (ACL) Reconstruction With Bone Tendon Bone Autograft With Versus Without Internal Bracing

A study testing ACL reconstruction with BTB autograft with internal brace augmentation (suture tape), ACL reconstruction with BTB autograft without internal brace augmentation (suture tape) and Standardized Rehabilitation Protocol in people with ACL Tear, run by Columbia University.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

There is no consensus regarding the best surgical management of primary ACL tears. Recent evidence suggests that internal brace augmentation may increase load failure and therefore stabilize the graft in-situ at the time of ACL reconstruction. Read more about this study

Who is it for?
Ages 12 years and olderHealthy volunteers can take part
Conditions the study is for
ACL Tear
What is being tested?
ACL reconstruction with BTB autograft with internal brace augmentation (suture tape), ACL reconstruction with BTB autograft without internal brace augmentation (suture tape) and Standardized Rehabilitation Protocol
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
No sites listed yet
Study dates
Sep 2026to Sep 2032
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • patients 12 and older
  • patients seen by the Columbia University Sports Medicine Service
  • patients diagnosed with a first time ACL injury by clinical exam and MRI

Who cannot join

  • previous knee surgery
  • concurrent knee fracture or ligamentous injury on ipsilateral knee
  • neuromuscular disorder involving lower limb
  • inability/ unwillingness to adhere to protocol
  • anesthesia contraindications
  • lost to follow up

About this study

Official title: ACL Reconstruction With Bone Tendon Bone (BTB) Autograft With Versus Without Internal Brace - Clinical and Radiographic Outcomes

There is no consensus regarding the best surgical management of primary ACL tears. Recent evidence suggests that internal brace augmentation may increase load failure and therefore stabilize the graft in-situ at the time of ACL reconstruction. This prospective randomized controlled trial aims to compare the time to return to activity, and participant reported outcomes in participants with bone-tendon-bone ACL reconstruction with and without (control) internal brace augmentation.

Read the detailed description

Despite the wide variety of surgical approaches and grafts that can be used in an ACL reconstruction, graft failure and recurrent knee instability are nevertheless ubiquitous issues that have facilitated interest in ways to strengthen the graft at the time of surgery. While both animal and biomechanical models have strongly suggested improved graft strength and patient outcomes by utilizing suture tape augmentation in ACL reconstructions, there is scant clinical literature available to assess these extrapolations. A retrospective cohort study of 60 patients undergoing ACL reconstruction with a hamstring autograft or allograft (30 suture tape vs 30 no suture tape; mean age: 30), found shorter time to return to activity (9.2 months suture tape group vs 12.9 months no suture tape group; p=0.002), lower Western Ontario and McMaster University Osteoarthritis Indices (WOMAC) (2.2 suture tape group vs 6.2 no suture tape group; p=0.024), higher international knee documentation committee (IKDC) scores (87.6 suture tape group vs 73.2 no suture tape group; p=0.006), lower average pain on the national pain rating scale (NPRS) (0.6 suture tape group vs 1.66 no suture tape group; p=0.021) and no significant difference in range of motion in degrees (129 suture tape group vs 127 no suture tape group; p=0.46), knee injury and osteoarthritis outcome score (KOOS) (92.2 suture tape group vs 87.1 no suture tape group; p=0.68), or complications (13% suture tape vs 10% no suture tape; p>0.05) at 2 years follow up. A retrospective cohort study of 108 patients undergoing ACL reconstruction with a hamstring autograft with and without suture tape reinforcement (36 suture tape vs 72 no suture tape; mean age: 25), found a significantly higher Tegner activity score (7.1 suture tape group vs 6.4 no suture tape group; p=0.026) but otherwise no significant difference in time to preinjury activity level (11.9 mos suture tape group vs 11.6 no suture tape group; p=0.59), range of motion (degrees) (136 suture tape group vs 137 no suture tape group; p=0.44) , Lysholm knee score (95.6 suture tape group vs 94 no suture tape group; p=0.165), IKDC score (94.4 suture tape group vs 93.8 no suture tape group; p=0.44), or complications (6% suture tape group vs 5% no suture tape group; p>0.05) at 2 years follow up. A prospective cohort study of 50 ACL reconstructions with hamstring autograft with and without suture tape reinforcement (25 suture tape group vs 25 no suture tape group; mean age: 30), found a significant improvement in greater than 2 grades of Lachman testing from preoperative assessment compared to 6 months follow-up (68% suture tape group vs 32% no suture tape group; p=0.039) but no difference in Lysholm knee score at 6 months (87.0 suture tape group vs 87.0 no suture tape group; p=0.756). Moreover, none of the already-limited clinical data investigates the use of internal braces with bone-tendon-bone grafts, which are a popular choice for young adults and athletes. Furthermore, there are no current level 1 data on this subject. Therefore, this study aims to compare the time to return to pre- injury activity level, incidence of recurrent knee instability, and patient reported outcomes of patients treated with ACL reconstruction using bone-tendon-bone autograft with and without (control group) internal brace stabilization.

Conditions
ACL Tear
Being tested
ACL reconstruction with BTB autograft with internal brace augmentation (suture tape), ACL reconstruction with BTB autograft without internal brace augmentation (suture tape), Standardized Rehabilitation Protocol
Medical subject headings
Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ACL reconstruction with BTB autograft with internal brace augmentation (suture tape)Procedure or surgery

    The ACL will be reconstructed using a participant's own patella tendon (BTB autograft), and the graft will be fortified by suture tape during the surgery in order to strengthen it.

  • ACL reconstruction with BTB autograft without internal brace augmentation (suture tape)Procedure or surgery

    The ACL will be reconstructed using a participant's own patella tendon (BTB autograft). The graft will not be fortified by suture tape in this group. It will be used as is without any modification.

  • Standardized Rehabilitation ProtocolOther

    Participants will undergo a standardized rehabilitation protocol with twice weekly physical therapy

Study groups in NCT05532189
Study groupRoleWhat they receive
ACL reconstruction with internal brace augmentation (suture tape)ExperimentalThis group will receive a standard ACL reconstruction using a BTB autograft with suture tape augmentation on the graft to strengthen it during the surgical procedure.
Receives: Procedure: ACL reconstruction with BTB autograft with internal brace augmentation (suture tape); Other: Standardized Rehabilitation Protocol
ACL reconstruction without internal brace augmentationActive comparatorThis group will only receive a standard ACL reconstruction using a BTB autograft. No suture tape will be added to the graft during the surgical procedure.
Receives: Procedure: ACL reconstruction with BTB autograft without internal brace augmentation (suture tape); Other: Standardized Rehabilitation Protocol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to Return to Full Activity or Sports

    Time from treatment initiation to full return to pre-injury activity levels in each group, expressed in weeks

    Measured: Measured once per participant, depending on the time required to return to full activity (up to 10 years)

  2. Percentage of Participants with Recurrent Knee Instability

    Percentage of participants that experience recurrent instability after treatment starts at each time point

    Measured: 2 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 years, 5 years and 10 years

  3. Change in Patient Reported Outcome Measurement Information System (PROMIS) Physical Function (PF) Computer Adaptive Test (CAT) at 2 weeks

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's physical functional capacity has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 2 weeks

  4. Change in PROMIS PF CAT at 6 weeks

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's physical functional capacity has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 6 weeks

  5. Change in PROMIS PF CAT at 3 months

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's physical functional capacity has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 3 months

  6. Change in PROMIS PF CAT at 6 months

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's physical functional capacity has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 6 months

  7. Change in PROMIS PF CAT at 1 year

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's physical functional capacity has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 1 year

  8. Change in PROMIS PF CAT at 2 years

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's physical functional capacity has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 2 years

  9. Change in PROMIS PF CAT at 5 years

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's physical functional capacity has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 5 years

  10. Change in PROMIS PF CAT at 10 years

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's physical functional capacity has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 10 years

  11. Change in PROMIS Pain Interference (PI) CAT at 2 weeks

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's pain has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 2 weeks

  12. Change in PROMIS PI CAT at 6 weeks

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's pain has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 6 weeks

  13. Change in PROMIS PI CAT at 3 months

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's pain has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 3 months

  14. Change in PROMIS PI CAT at 6 months

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's pain has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 6 months

  15. Change in PROMIS PI CAT at 1 year

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's pain has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 1 year

  16. Change in PROMIS PI CAT at 2 years

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's pain has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 2 years

  17. Change in PROMIS PI CAT at 5 years

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's pain has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 5 years

  18. Change in PROMIS PI CAT at 10 years

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's pain has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 10 years

  19. Change in PROMIS Depression CAT at 2 weeks

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's quality of life has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 2 weeks

  20. Change in PROMIS Depression CAT at 6 weeks

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's quality of life has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 6 weeks

  21. Change in PROMIS Depression CAT at 3 months

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's quality of life has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 3 months

  22. Change in PROMIS Depression CAT at 6 months

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's quality of life has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 6 months

  23. Change in PROMIS Depression CAT at 1 year

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's quality of life has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 1 year

  24. Change in PROMIS Depression CAT at 2 years

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's quality of life has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 2 years

  25. Change in PROMIS Depression CAT at 5 years

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's quality of life has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 5 years

  26. Change in PROMIS Depression CAT at 10 years

    A computerized questionnaire ranging from 0 to 100 points that addresses how a participant's quality of life has been impacted by their knee injury. A lower score indicates a better outcome.

    Measured: Baseline and 10 years

Secondary outcomes (48)
  1. Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC) Score at 2 weeks

    The WOMAC questionnaire has subscores for pain (0-20), stiffness (0-8), and physical function (0-68), which address the impact of an injury on a participant's life. A lower total score (sum of subscores) indicates a better outcome.

    Measured: Baseline and 2 weeks

  2. Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC) Score at 6 weeks

    The WOMAC questionnaire has subscores for pain (0-20), stiffness (0-8), and physical function (0-68), which address the impact of an injury on a participant's life. A lower total score (sum of subscores) indicates a better outcome.

    Measured: Baseline and 6 weeks

  3. Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC) Score at 3 months

    The WOMAC questionnaire has subscores for pain (0-20), stiffness (0-8), and physical function (0-68), which address the impact of an injury on a participant's life. A lower total score (sum of subscores) indicates a better outcome.

    Measured: Baseline and 3 months

  4. Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC) Score at 6 months

    The WOMAC questionnaire has subscores for pain (0-20), stiffness (0-8), and physical function (0-68), which address the impact of an injury on a participant's life. A lower total score (sum of subscores) indicates a better outcome.

    Measured: Baseline and 6 months

  5. Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC) Score at 1 year

    The WOMAC questionnaire has subscores for pain (0-20), stiffness (0-8), and physical function (0-68), which address the impact of an injury on a participant's life. A lower total score (sum of subscores) indicates a better outcome.

    Measured: Baseline and 1 year

  6. Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC) Score at 2 years

    The WOMAC questionnaire has subscores for pain (0-20), stiffness (0-8), and physical function (0-68), which address the impact of an injury on a participant's life. A lower total score (sum of subscores) indicates a better outcome.

    Measured: Baseline and 2 years

  7. Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC) Score at 5 years

    The WOMAC questionnaire has subscores for pain (0-20), stiffness (0-8), and physical function (0-68), which address the impact of an injury on a participant's life. A lower total score (sum of subscores) indicates a better outcome.

    Measured: Baseline and 5 years

  8. Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC) Score at 10 years

    The WOMAC questionnaire has subscores for pain (0-20), stiffness (0-8), and physical function (0-68), which address the impact of an injury on a participant's life. A lower total score (sum of subscores) indicates a better outcome.

    Measured: Baseline and 10 years

  9. Change in International Knee Documentation Committee (IKDC) Score at 2 weeks

    The IKDC questionnaire is scored from 0 (worse outcome)-100 (better outcome) and addresses knee symptoms, function, and physical activity.

    Measured: Baseline and 2 weeks

  10. Change in International Knee Documentation Committee (IKDC) Score at 6 weeks

    The IKDC questionnaire is scored from 0 (worse outcome)-100 (better outcome) and addresses knee symptoms, function, and physical activity.

    Measured: Baseline and 6 weeks

  11. Change in International Knee Documentation Committee (IKDC) Score at 3 months

    The IKDC questionnaire is scored from 0 (worse outcome)-100 (better outcome) and addresses knee symptoms, function, and physical activity.

    Measured: Baseline and 3 months

  12. Change in International Knee Documentation Committee (IKDC) Score at 6 months

    The IKDC questionnaire is scored from 0 (worse outcome)-100 (better outcome) and addresses knee symptoms, function, and physical activity.

    Measured: Baseline and 6 months

  13. Change in International Knee Documentation Committee (IKDC) Score at 1 year

    The IKDC questionnaire is scored from 0 (worse outcome)-100 (better outcome) and addresses knee symptoms, function, and physical activity.

    Measured: Baseline and 1 year

  14. Change in International Knee Documentation Committee (IKDC) Score at 2 years

    The IKDC questionnaire is scored from 0 (worse outcome)-100 (better outcome) and addresses knee symptoms, function, and physical activity.

    Measured: Baseline and 2 years

  15. Change in International Knee Documentation Committee (IKDC) Score at 5 years

    The IKDC questionnaire is scored from 0 (worse outcome)-100 (better outcome) and addresses knee symptoms, function, and physical activity.

    Measured: Baseline and 5 years

  16. Change in International Knee Documentation Committee (IKDC) Score at 10 years

    The IKDC questionnaire is scored from 0 (worse outcome)-100 (better outcome) and addresses knee symptoms, function, and physical activity.

    Measured: Baseline and 10 years

  17. Change in numeric pain rating scale (NPRS) Score at 2 weeks

    The NPRS is a questionnaire on a visual analog scale of 0 to 10 that a participant rates based on how bad their pain is (0 = no pain; 10 = maximum pain)

    Measured: Baseline and 2 weeks

  18. Change in numeric pain rating scale (NPRS) Score at 6 weeks

    The NPRS is a questionnaire on a visual analog scale of 0 to 10 that a participant rates based on how bad their pain is (0 = no pain; 10 = maximum pain)

    Measured: Baseline and 6 weeks

  19. Change in numeric pain rating scale (NPRS) Score at 3 months

    The NPRS is a questionnaire on a visual analog scale of 0 to 10 that a participant rates based on how bad their pain is (0 = no pain; 10 = maximum pain)

    Measured: Baseline and 3 months

  20. Change in numeric pain rating scale (NPRS) Score at 6 months

    The NPRS is a questionnaire on a visual analog scale of 0 to 10 that a participant rates based on how bad their pain is (0 = no pain; 10 = maximum pain)

    Measured: Baseline and 6 months

  21. Change in numeric pain rating scale (NPRS) Score at 1 year

    The NPRS is a questionnaire on a visual analog scale of 0 to 10 that a participant rates based on how bad their pain is (0 = no pain; 10 = maximum pain)

    Measured: Baseline and 1 year

  22. Change in numeric pain rating scale (NPRS) Score at 2 years

    The NPRS is a questionnaire on a visual analog scale of 0 to 10 that a participant rates based on how bad their pain is (0 = no pain; 10 = maximum pain)

    Measured: Baseline and 2 years

  23. Change in numeric pain rating scale (NPRS) Score at 5 years

    The NPRS is a questionnaire on a visual analog scale of 0 to 10 that a participant rates based on how bad their pain is (0 = no pain; 10 = maximum pain)

    Measured: Baseline and 5 years

  24. Change in numeric pain rating scale (NPRS) Score at 10 years

    The NPRS is a questionnaire on a visual analog scale of 0 to 10 that a participant rates based on how bad their pain is (0 = no pain; 10 = maximum pain)

    Measured: Baseline and 10 years

  25. Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) at 2 weeks

    The KOOS score is a questionnaire regarding the severity of participants' knee symptoms, which is scored from 0 to 100 (100 representing no severity; 0 representing maximum severity )

    Measured: Baseline and 2 weeks

  26. Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) at 6 weeks

    The KOOS score is a questionnaire regarding the severity of participants' knee symptoms, which is scored from 0 to 100 (100 representing no severity; 0 representing maximum severity )

    Measured: Baseline and 6 weeks

  27. Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) at 3 months

    The KOOS score is a questionnaire regarding the severity of participants' knee symptoms, which is scored from 0 to 100 (100 representing no severity; 0 representing maximum severity )

    Measured: Baseline and 3 months

  28. Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) at 6 months

    The KOOS score is a questionnaire regarding the severity of participants' knee symptoms, which is scored from 0 to 100 (100 representing no severity; 0 representing maximum severity )

    Measured: Baseline and 6 months

  29. Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) at 1 year

    The KOOS score is a questionnaire regarding the severity of participants' knee symptoms, which is scored from 0 to 100 (100 representing no severity; 0 representing maximum severity )

    Measured: Baseline and 1 year

  30. Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) at 2 years

    The KOOS score is a questionnaire regarding the severity of participants' knee symptoms, which is scored from 0 to 100 (100 representing no severity; 0 representing maximum severity )

    Measured: Baseline and 2 years

  31. Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) at 5 years

    The KOOS score is a questionnaire regarding the severity of participants' knee symptoms, which is scored from 0 to 100 (100 representing no severity; 0 representing maximum severity )

    Measured: Baseline and 5 years

  32. Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) at 10 years

    The KOOS score is a questionnaire regarding the severity of participants' knee symptoms, which is scored from 0 to 100 (100 representing no severity; 0 representing maximum severity )

    Measured: Baseline and 10 years

  33. Change in Tegner activity scale (TAS) Score at 2 weeks

    TAS is a one-item questionnaire assessing the activity level of patients on a scale of 0-10, with 0 representing disability and 10 representing the level of a professional athlete.

    Measured: Baseline and 2 weeks

  34. Change in Tegner activity scale (TAS) Score at 6 weeks

    TAS is a one-item questionnaire assessing the activity level of patients on a scale of 0-10, with 0 representing disability and 10 representing the level of a professional athlete.

    Measured: Baseline and 6 weeks

  35. Change in Tegner activity scale (TAS) Score at 3 months

    TAS is a one-item questionnaire assessing the activity level of patients on a scale of 0-10, with 0 representing disability and 10 representing the level of a professional athlete.

    Measured: Baseline and 3 months

  36. Change in Tegner activity scale (TAS) Score at 6 months

    TAS is a one-item questionnaire assessing the activity level of patients on a scale of 0-10, with 0 representing disability and 10 representing the level of a professional athlete.

    Measured: Baseline and 6 months

  37. Change in Tegner activity scale (TAS) Score at 1 year

    TAS is a one-item questionnaire assessing the activity level of patients on a scale of 0-10, with 0 representing disability and 10 representing the level of a professional athlete.

    Measured: Baseline and 1 year

  38. Change in Tegner activity scale (TAS) Score at 2 years

    TAS is a one-item questionnaire assessing the activity level of patients on a scale of 0-10, with 0 representing disability and 10 representing the level of a professional athlete.

    Measured: Baseline and 2 years

  39. Change in Tegner activity scale (TAS) Score at 5 years

    TAS is a one-item questionnaire assessing the activity level of patients on a scale of 0-10, with 0 representing disability and 10 representing the level of a professional athlete.

    Measured: Baseline and 5 years

  40. Change in Tegner activity scale (TAS) Score at 10 years

    TAS is a one-item questionnaire assessing the activity level of patients on a scale of 0-10, with 0 representing disability and 10 representing the level of a professional athlete.

    Measured: Baseline and 10 years

  41. Change in Lysholm Score at 2 weeks

    Lysholm score is a questionnaire out of 100 points that addresses specific aspects of participant's knee symptoms, with 100 indicating little to no symptoms and 0 indicating severe symptoms.

    Measured: Baseline and 2 weeks

  42. Change in Lysholm Score at 6 weeks

    Lysholm score is a questionnaire out of 100 points that addresses specific aspects of participant's knee symptoms, with 100 indicating little to no symptoms and 0 indicating severe symptoms.

    Measured: Baseline and 6 weeks

  43. Change in Lysholm Score at 3 months

    Lysholm score is a questionnaire out of 100 points that addresses specific aspects of participant's knee symptoms, with 100 indicating little to no symptoms and 0 indicating severe symptoms.

    Measured: Baseline and 3 months

  44. Change in Lysholm Score at 6 months

    Lysholm score is a questionnaire out of 100 points that addresses specific aspects of participant's knee symptoms, with 100 indicating little to no symptoms and 0 indicating severe symptoms.

    Measured: Baseline and 6 months

  45. Change in Lysholm Score at 1 year

    Lysholm score is a questionnaire out of 100 points that addresses specific aspects of participant's knee symptoms, with 100 indicating little to no symptoms and 0 indicating severe symptoms.

    Measured: Baseline and 1 year

  46. Change in Lysholm Score at 2 years

    Lysholm score is a questionnaire out of 100 points that addresses specific aspects of participant's knee symptoms, with 100 indicating little to no symptoms and 0 indicating severe symptoms.

    Measured: Baseline and 2 years

  47. Change in Lysholm Score at 5 years

    Lysholm score is a questionnaire out of 100 points that addresses specific aspects of participant's knee symptoms, with 100 indicating little to no symptoms and 0 indicating severe symptoms.

    Measured: Baseline and 5 years

  48. Change in Lysholm Score at 10 years

    Lysholm score is a questionnaire out of 100 points that addresses specific aspects of participant's knee symptoms, with 100 indicating little to no symptoms and 0 indicating severe symptoms.

    Measured: Baseline and 10 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2022
  2. Study startSep 2026 (estimated)
  3. Primary completionSep 2032 (estimated)
  4. Study completionSep 2032 (estimated)

Why it stopped: PI left institution

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomized to the ACL reconstruction without internal bracing group (control) or to the ACL reconstruction with internal bracing (experimental).
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05532189
Sponsor's protocol ID
AAAU0966
Status last verified
Sep 2026
First submitted
4 Sep 2022
Last updated
21 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Mall NA, Chalmers PN, Moric M, Tanaka MJ, Cole BJ, Bach BR Jr, Paletta GA Jr. Incidence and trends of anterior cruciate ligament reconstruction in the United States. Am J Sports Med. 2014 Oct;42(10):2363-70. doi: 10.1177/0363546514542796. Epub 2014 Aug 1.

    PubMed 25086064
  • Cohen SB, Yucha DT, Ciccotti MC, Goldstein DT, Ciccotti MA, Ciccotti MG. Factors affecting patient selection of graft type in anterior cruciate ligament reconstruction. Arthroscopy. 2009 Sep;25(9):1006-10. doi: 10.1016/j.arthro.2009.02.010.

    PubMed 19732639
  • Spindler KP, Wright RW. Clinical practice. Anterior cruciate ligament tear. N Engl J Med. 2008 Nov 13;359(20):2135-42. doi: 10.1056/NEJMcp0804745. No abstract available.

    PubMed 19005197
  • Engebretsen L, Benum P, Fasting O, Molster A, Strand T. A prospective, randomized study of three surgical techniques for treatment of acute ruptures of the anterior cruciate ligament. Am J Sports Med. 1990 Nov-Dec;18(6):585-90. doi: 10.1177/036354659001800605.

    PubMed 2285086
  • Bowman EN, Limpisvasti O, Cole BJ, ElAttrache NS. Anterior Cruciate Ligament Reconstruction Graft Preference Most Dependent on Patient Age: A Survey of United States Surgeons. Arthroscopy. 2021 May;37(5):1559-1566. doi: 10.1016/j.arthro.2021.01.042. Epub 2021 Feb 1.

    PubMed 33539983
  • Bodendorfer BM, Michaelson EM, Shu HT, Apseloff NA, Spratt JD, Nolton EC, Argintar EH. Suture Augmented Versus Standard Anterior Cruciate Ligament Reconstruction: A Matched Comparative Analysis. Arthroscopy. 2019 Jul;35(7):2114-2122. doi: 10.1016/j.arthro.2019.01.054. Epub 2019 Jun 2.

    PubMed 31167738
  • Parkes CW, Leland DP, Levy BA, Stuart MJ, Camp CL, Saris DBF, Krych AJ. Hamstring Autograft Anterior Cruciate Ligament Reconstruction Using an All-Inside Technique With and Without Independent Suture Tape Reinforcement. Arthroscopy. 2021 Feb;37(2):609-616. doi: 10.1016/j.arthro.2020.09.002. Epub 2020 Nov 2.

    PubMed 33144236
  • Batty LM, Norsworthy CJ, Lash NJ, Wasiak J, Richmond AK, Feller JA. Synthetic devices for reconstructive surgery of the cruciate ligaments: a systematic review. Arthroscopy. 2015 May;31(5):957-68. doi: 10.1016/j.arthro.2014.11.032. Epub 2015 Jan 22.

    PubMed 25620500
  • Smith PA, Bley JA. Allograft Anterior Cruciate Ligament Reconstruction Utilizing Internal Brace Augmentation. Arthrosc Tech. 2016 Oct 10;5(5):e1143-e1147. doi: 10.1016/j.eats.2016.06.007. eCollection 2016 Oct.

    PubMed 28224069
  • E A Mackenzie C, Huntington LS, Tulloch S. Suture Tape Augmentation of Anterior Cruciate Ligament Reconstruction Increases Biomechanical Stability: A Scoping Review of Biomechanical, Animal, and Clinical Studies. Arthroscopy. 2022 Jun;38(6):2073-2089. doi: 10.1016/j.arthro.2021.12.036. Epub 2022 Jan 3.

    PubMed 34990759

Questions about this trial

What is this clinical trial studying?

A study testing ACL reconstruction with BTB autograft with internal brace augmentation (suture tape), ACL reconstruction with BTB autograft without internal brace augmentation (suture tape) and Standardized Rehabilitation Protocol in people with ACL Tear, run by Columbia University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 21 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to Return to Full Activity or Sports (time frame: Measured once per participant, depending on the time required to return to full activity (up to 10 years)). The study lists 26 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05532189, which also lists 10 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in